<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33274234</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>04</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>18</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2314-6141</ISSN><JournalIssue CitedMedium="Internet"><Volume>2020</Volume><PubDate><Year>2020</Year></PubDate></JournalIssue><Title>BioMed research international</Title><ISOAbbreviation>Biomed Res Int</ISOAbbreviation></Journal><ArticleTitle>Incidence of Infection of Enterovirus 71 and Coxsackieviruses A6 and A16 among Household Contacts of Index Cases in Dong Thap Province, Southern Vietnam.</ArticleTitle><Pagination><StartPage>9850351</StartPage><MedlinePgn>9850351</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">9850351</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1155/2020/9850351</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Scarce information exists about immunity to hand, foot, and mouth disease (HFMD) among household contacts of index cases in Vietnam and what that means for reducing ongoing HFMD transmission in the community.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We analyzed neutralizing antibodies (NT) and the incidence of enterovirus (EVs) infection among household contacts of index cases in a province where HFMD remains endemic. Throat swab and 2&#x2009;mL blood samples from household contacts were collected at enrollment, during and after 2 weeks follow-up.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The incidence of EV-A71 infection among household contacts was 40/84 (47.6%, 95% Cl: 36.9-58.3%), compared with 106/336 (31.5%, 95% Cl: 26.6-36.5%) for CV-A6 and 36/107 (33.6%, 95% Cl: 24.7-42.6%) for CV-A16. The incidence of CV-A6 infection was fairly constant across ages; in contrast, CV-A71 and CV-A16 had some variation across ages. At baseline, higher geometric mean titer (GMT) of EV-A71, CV-A6, and CV-A16 antibody titers was found for 25-34-year groups (range 216.3 to 305.0) compared to the other age groups. There was a statistically significant difference in GMT values of CV-A6 and CV-A16 between those who had an infection or did not have infection among households with an index case of these serotypes.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our results indicated that adults were becoming infected with HFMD and could be contributing to the transmission. There is, therefore, a need for considering the household setting as an additional target for intervention programs for HFMD.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 C. Q. Hoang et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hoang</LastName><ForeName>C Q</ForeName><Initials>CQ</Initials><Identifier Source="ORCID">0000-0003-1934-7138</Identifier><AffiliationInfo><Affiliation>Directorial Board, Pasteur Institute in Ho Chi Minh City, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>H D</ForeName><Initials>HD</Initials><Identifier Source="ORCID">0000-0001-8419-7784</Identifier><AffiliationInfo><Affiliation>Planning Division, Pasteur Institute in Ho Chi Minh City, Vietnam.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pasteur Institute in Ho Chi Minh City, Vietnam 167 Pasteur Street, District 3, Ho Chi Minh City, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ho</LastName><ForeName>N X</ForeName><Initials>NX</Initials><AffiliationInfo><Affiliation>Training Center, Pasteur Institute in Ho Chi Minh City, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vu</LastName><ForeName>T H T</ForeName><Initials>THT</Initials><AffiliationInfo><Affiliation>Microbiology and Immunology Department, Pasteur Institute in Ho Chi Minh City, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pham</LastName><ForeName>T T M</ForeName><Initials>TTM</Initials><AffiliationInfo><Affiliation>Microbiology and Immunology Department, Pasteur Institute in Ho Chi Minh City, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>K T</ForeName><Initials>KT</Initials><AffiliationInfo><Affiliation>Microbiology and Immunology Department, Pasteur Institute in Ho Chi Minh City, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>H T</ForeName><Initials>HT</Initials><AffiliationInfo><Affiliation>Training Center, Pasteur Institute in Ho Chi Minh City, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoang</LastName><ForeName>L T</ForeName><Initials>LT</Initials><AffiliationInfo><Affiliation>Medical Testing and Calibration Centers, Ho Chi Minh City Pasteur Institute, Ho Chi Minh, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clapham</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Saw Swee Hock School of Public Health, National University of Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>T T T</ForeName><Initials>TTT</Initials><AffiliationInfo><Affiliation>Microbiology and Immunology Department, Pasteur Institute in Ho Chi Minh City, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Phan</LastName><ForeName>L T</ForeName><Initials>LT</Initials><AffiliationInfo><Affiliation>Directorial Board, Pasteur Institute in Ho Chi Minh City, Vietnam.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>11</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Biomed Res Int</MedlineTA><NlmUniqueID>101600173</NlmUniqueID></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D057134">Antibodies, Neutralizing</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057134" MajorTopicYN="N">Antibodies, Neutralizing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="N">Coxsackievirus Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005191" MajorTopicYN="Y">Family Characteristics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016036" MajorTopicYN="N">Seroepidemiologic Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065288" MajorTopicYN="N">Serogroup</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014744" MajorTopicYN="N" Type="Geographic">Vietnam</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019562" MajorTopicYN="N">Viral Load</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The author declares that there are no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>5</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>9</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>11</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>12</Month><Day>4</Day><Hour>5</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>12</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>11</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33274234</ArticleId><ArticleId IdType="pmc">PMC7695493</ArticleId><ArticleId IdType="doi">10.1155/2020/9850351</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ooi M. H., Wong S. C., Lewthwaite P., Cardosa M. J., Solomon T. Clinical features, diagnosis, and management of enterovirus 71. The Lancet Neurology. 2010;9(11):1097&#x2013;1105. doi: 10.1016/S1474-4422(10)70209-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70209-X</ArticleId><ArticleId IdType="pubmed">20965438</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T., Lewthwaite P., Perera D., Cardosa M. J., McMinn P., Ooi M. H. Virology, epidemiology, pathogenesis, and control of enterovirus 71. The Lancet Infectious Diseases. 2010;10(11):778&#x2013;790. doi: 10.1016/S1473-3099(10)70194-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(10)70194-8</ArticleId><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Koroleva G., Lukashev A. N., Khudiakova L. V., Mustafina A. N., Lashkevich V. A. Encephalomyelitis caused by enterovirus type 71 in children. Voprosy Virusologii. 2010;55(6):4&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">21381332</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran C. B. N., Nguyen H. T., Phan H. T. T., et al. The Seroprevalence and Seroincidence of Enterovirus71 Infection in Infants and Children in Ho Chi Minh City, Viet Nam. PLoS ONE. 2011;6(7):p. e21116. doi: 10.1371/journal.pone.0021116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0021116</ArticleId><ArticleId IdType="pmc">PMC3134465</ArticleId><ArticleId IdType="pubmed">21765891</ArticleId></ArticleIdList></Reference><Reference><Citation>Khanh T. H., Sabanathan S., Thanh T. T., et al. Enterovirus 71&#x2013;associated hand, foot, and mouth disease, southern Vietnam, 2011. Emerging Infectious Diseases. 2012;18(12):2002&#x2013;2005. doi: 10.3201/eid1812.120929.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1812.120929</ArticleId><ArticleId IdType="pmc">PMC3557876</ArticleId><ArticleId IdType="pubmed">23194699</ArticleId></ArticleIdList></Reference><Reference><Citation>Anh N. T., Nhu L. N. T., van H. M. T., et al. Emerging coxsackievirus A6 causing hand, foot and mouth disease, Vietnam. Emerging Infectious Diseases. 2018;24(4):654&#x2013;662. doi: 10.3201/eid2404.171298.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2404.171298</ArticleId><ArticleId IdType="pmc">PMC5875260</ArticleId><ArticleId IdType="pubmed">29553326</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoang C. Q., Nguyen T. T. T., Ho N. X., et al. Transmission and serotype features of hand foot mouth disease in household contacts in Dong Thap, Vietnam. BMC Infectious Diseases. 2019;19(1):p. 933. doi: 10.1186/s12879-019-4583-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-019-4583-1</ArticleId><ArticleId IdType="pmc">PMC6833133</ArticleId><ArticleId IdType="pubmed">31690269</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Hoang M. T., To anh Nguyen, Tran T. T., et al. Clinical and aetiological study of hand, foot and mouth disease in southern Vietnam, 2013&#x2013;2015: Inpatients and outpatients. International Journal of Infectious Diseases. 2019;80:1&#x2013;9. doi: 10.1016/j.ijid.2018.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2018.12.004</ArticleId><ArticleId IdType="pmc">PMC6403263</ArticleId><ArticleId IdType="pubmed">30550944</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen N. T. B., Pham H. V., Hoang C. Q., et al. Epidemiological and clinical characteristics of children who died from hand, foot and mouth disease in Vietnam, 2011. BMC Infectious Diseases. 2014;14(1) doi: 10.1186/1471-2334-14-341.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-14-341</ArticleId><ArticleId IdType="pmc">PMC4068316</ArticleId><ArticleId IdType="pubmed">24942066</ArticleId></ArticleIdList></Reference><Reference><Citation>Chong P., Liu C. C., Chow Y. H., Chou A. H., Klein M. Review of enterovirus 71 vaccines. Clinical Infectious Diseases. 2015;60(5):797&#x2013;803. doi: 10.1093/cid/ciu852.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciu852</ArticleId><ArticleId IdType="pubmed">25352588</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu F., Xu W., Xia J., et al. Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China. New England Journal of Medicine. 2014;370(9):818&#x2013;828. doi: 10.1056/NEJMoa1304923.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1304923</ArticleId><ArticleId IdType="pubmed">24571754</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L., Yin H., An Z., Feng Z. Considerations for developing an immunization strategy with enterovirus 71 vaccine. Vaccine. 2015;33(9):1107&#x2013;1112. doi: 10.1016/j.vaccine.2014.10.081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2014.10.081</ArticleId><ArticleId IdType="pubmed">25444807</ArticleId></ArticleIdList></Reference><Reference><Citation>Ministry of Health. Vietnam, Decision No.581/Q&#x110;-BYT. Guidance for prevention, control and surveillance of hand food and mounth disease. 2012.  March 2020  https://thuvienphapluat.vn/van-ban/the-thao-y-te/Quyet-dinh-581-QD-BYT-giam-sat-va-phong-chong-benh-tay-chan-mieng-135592.aspx.</Citation></Reference><Reference><Citation>Koh W. M., Badaruddin H., la H., Chen M. I. C., Cook A. R. Severity and burden of hand, foot and mouth disease in Asia: a modelling study. BMJ Global Health. 2018;3(1) doi: 10.1136/bmjgh-2017-000442.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2017-000442</ArticleId><ArticleId IdType="pmc">PMC5859810</ArticleId><ArticleId IdType="pubmed">29564154</ArticleId></ArticleIdList></Reference><Reference><Citation>Thao N. T. T., Ngoc N. T. K., T&#xfa; P. V., et al. Development of a multiplex polymerase chain reaction assay for simultaneous identification of human enterovirus 71 and coxsackievirus A16. Journal of Virological Methods. 2010;170(1-2):134&#x2013;139. doi: 10.1016/j.jviromet.2010.09.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2010.09.017</ArticleId><ArticleId IdType="pmc">PMC2995219</ArticleId><ArticleId IdType="pubmed">20863857</ArticleId></ArticleIdList></Reference><Reference><Citation>Nix W. A., Oberste M. S., Pallansch M. A. Sensitive, seminested PCR amplification of VP1 sequences for direct identification of all enterovirus serotypes from original clinical specimens. Journal of Clinical Microbiology. 2006;44(8):2698&#x2013;2704. doi: 10.1128/JCM.00542-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00542-06</ArticleId><ArticleId IdType="pmc">PMC1594621</ArticleId><ArticleId IdType="pubmed">16891480</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Van Tan N. T. K. T., Thanh T. T., Ngan T. T., et al. A generic assay for whole-genome amplification and deep sequencing of enterovirus A71. Journal of Virological Methods. 2015;215-216:30&#x2013;36. doi: 10.1016/j.jviromet.2015.02.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2015.02.011</ArticleId><ArticleId IdType="pmc">PMC4374682</ArticleId><ArticleId IdType="pubmed">25704598</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu F.-C., Liang Z.-L., Meng F.-Y., et al. Retrospective Study of the Incidence of HFMD and Seroepidemiology of Antibodies against EV71 and CoxA16 in Prenatal Women and Their Infants. PLoS ONE. 2012;7(5)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3360679</ArticleId><ArticleId IdType="pubmed">22662137</ArticleId></ArticleIdList></Reference><Reference><Citation>Lerdsamran H., Prasertsopon J., Mungaomklang A., et al. Seroprevalence of antibodies to enterovirus 71 and coxsackievirus A16 among people of various age groups in a northeast province of Thailand. Virology Journal. 2018;15(1):p. 158. doi: 10.1186/s12985-018-1074-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-018-1074-8</ArticleId><ArticleId IdType="pmc">PMC6192276</ArticleId><ArticleId IdType="pubmed">30326914</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J., Jiang F., Zhong L., Sun J., Ding J. Age patterns and transmission characteristics of hand, foot and mouth disease in China. BMC Infectious Diseases. 2016;16(1):p. 691. doi: 10.1186/s12879-016-2008-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-016-2008-y</ArticleId><ArticleId IdType="pmc">PMC5117511</ArticleId><ArticleId IdType="pubmed">27871252</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu J., Yan H., Cheng N., et al. The Clinical and Epidemiological Study of Children with Hand, Foot, and Mouth Disease in Hunan, China from 2013 to 2017. Scientific Reports. 2019;9(1):p. 11662. doi: 10.1038/s41598-019-48259-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-48259-1</ArticleId><ArticleId IdType="pmc">PMC6690890</ArticleId><ArticleId IdType="pubmed">31406192</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Teng Z., Cui X., et al. Epidemiological and serological surveillance of hand-foot-and-mouth disease in Shanghai, China, 2012&#x2013;2016. Emerging Microbes &amp; Infections. 2018;7(1):1&#x2013;12. doi: 10.1038/s41426-017-0011-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41426-017-0011-z</ArticleId><ArticleId IdType="pmc">PMC5837173</ArticleId><ArticleId IdType="pubmed">29362406</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin J. U., Oh S. H., Lee J. H. A case of hand-foot-mouth disease in an immunocompetent adult. Annals of Dermatology. 2010;22(2):216&#x2013;218. doi: 10.5021/ad.2010.22.2.216.</Citation><ArticleIdList><ArticleId IdType="doi">10.5021/ad.2010.22.2.216</ArticleId><ArticleId IdType="pmc">PMC2883431</ArticleId><ArticleId IdType="pubmed">20548919</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaminska K., Martinetti G., Lucchini R., Kaya G., Mainetti C. Coxsackievirus A6 and hand, foot and mouth disease: three case reports of familialchild-to-immunocompetent adult transmission and a literature review. Case Reports in Dermatology. 2013;5(2):203&#x2013;209. doi: 10.1159/000354533.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000354533</ArticleId><ArticleId IdType="pmc">PMC3764954</ArticleId><ArticleId IdType="pubmed">24019771</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris P. N. A., Wang A. D., Yin M., Lee C. K., Archuleta S. Atypical hand, foot, and mouth disease: eczema coxsackium can also occur in adults. The Lancet Infectious Diseases. 2014;14(11):p. 1043. doi: 10.1016/S1473-3099(14)70976-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(14)70976-4</ArticleId><ArticleId IdType="pubmed">25444404</ArticleId></ArticleIdList></Reference><Reference><Citation>Akiyama K., Imazeki R., Yoshii F., Koide T., Muto J. An adult case of hand, foot, and mouth disease caused by enterovirus 71 accompanied by opsoclonus myoclonica. The Tokai Journal of Experimental and Clinical Medicine. 2008;33(4):143&#x2013;145.</Citation><ArticleIdList><ArticleId IdType="pubmed">21318985</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramirez-Fort M. K., Downing C., Doan H. Q., et al. Coxsackievirus A6 associated hand, foot and mouth disease in adults: clinical presentation and review of the literature. Journal of Clinical Virology. 2014;60(4):381&#x2013;386. doi: 10.1016/j.jcv.2014.04.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2014.04.023</ArticleId><ArticleId IdType="pubmed">24932735</ArticleId></ArticleIdList></Reference><Reference><Citation>Cepeda C. O., Mart&#xed;nez-Valverde A., del Mar Sabater-Recolons M., Jan&#xe9;-Salas E., Mar&#xed;-Roig A., L&#xf3;pez J. L. A literature review and case report of hand, foot and mouth disease in an immunocompetent adult. BMC Research Notes. 2016;9(1):p. 165. doi: 10.1186/s13104-016-1973-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13104-016-1973-y</ArticleId><ArticleId IdType="pmc">PMC4791924</ArticleId><ArticleId IdType="pubmed">26975350</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang L.-Y., Tsao K. C., Hsia S. H., et al. Transmission and clinical features of enterovirus 71 infections in household contacts in Taiwan. JAMA. 2004;291(2):222&#x2013;227. doi: 10.1001/jama.291.2.222.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.291.2.222</ArticleId><ArticleId IdType="pubmed">14722149</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia F., Deng F., Tian H., He W., Xiao Y., Sun X. Estimation of the reproduction number and identification of periodicity for HFMD infections in Northwest China. Journal of Theoretical Biology. 2020;484:p. 110027. doi: 10.1016/j.jtbi.2019.110027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtbi.2019.110027</ArticleId><ArticleId IdType="pubmed">31568791</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei J., Hansen A., Liu Q., Sun Y., Weinstein P., Bi P. The effect of meteorological variables on the transmission of hand, foot and mouth disease in four major cities of Shanxi province, China: a time series data analysis (2009-2013) PLoS Neglected Tropical Diseases. 2015;9(3) doi: 10.1371/journal.pntd.0003572.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0003572</ArticleId><ArticleId IdType="pmc">PMC4351101</ArticleId><ArticleId IdType="pubmed">25742504</ArticleId></ArticleIdList></Reference><Reference><Citation>LIM C. T. K., JIANG L., MA S., JAMES L., ANG L. W. Basic reproduction number of coxsackievirus type A6 and A16 and enterovirus 71: estimates from outbreaks of hand, foot and mouth disease in Singapore, a tropical city-state. Epidemiology &amp; Infection. 2016;144(5):1028&#x2013;1034. doi: 10.1017/s0950268815002137.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/s0950268815002137</ArticleId><ArticleId IdType="pubmed">26374168</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayman R., Shepherd M., Tarring C., Best E. Outbreak of variant hand-foot-and-mouth disease caused by coxsackievirus A6 in Auckland, New Zealand. Journal of Paediatrics and Child Health. 2014;50(10):751&#x2013;755. doi: 10.1111/jpc.12708.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jpc.12708</ArticleId><ArticleId IdType="pubmed">25123330</ArticleId></ArticleIdList></Reference><Reference><Citation>Ang L. W., Tay J., Phoon M. C., et al. Seroepidemiology of Coxsackievirus A6, Coxsackievirus A16, and Enterovirus 71 Infections among Children and Adolescents in Singapore, 2008-2010. PLOS ONE. 2015;10(5) doi: 10.1371/journal.pone.0127999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0127999</ArticleId><ArticleId IdType="pmc">PMC4444285</ArticleId><ArticleId IdType="pubmed">26011735</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W., Yi L., Su J., et al. Seroepidemiology of human enterovirus71 and coxsackievirusA16 among children in Guangdong province, China. BMC Infectious Diseases. 2013;13(1) doi: 10.1186/1471-2334-13-322.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-13-322</ArticleId><ArticleId IdType="pmc">PMC3717138</ArticleId><ArticleId IdType="pubmed">23855481</ArticleId></ArticleIdList></Reference><Reference><Citation>NikNadia N. M. N., Sam I. C., Rampal S., et al. Cyclical patterns of hand, foot and mouth disease caused by enterovirus A71 in Malaysia. PLoS Neglected Tropical Diseases. 2016;10(3):p. e0004562. doi: 10.1371/journal.pntd.0004562.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0004562</ArticleId><ArticleId IdType="pmc">PMC4806993</ArticleId><ArticleId IdType="pubmed">27010319</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang J., Liao Q., Ooi M. H., et al. Epidemiology of Recurrent Hand, Foot and Mouth Disease, China, 2008&#x2013;2015. Emerging Infectious Diseases. 2018;24(3) doi: 10.3201/eid2403.171303.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2403.171303</ArticleId><ArticleId IdType="pmc">PMC5823341</ArticleId><ArticleId IdType="pubmed">29460747</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R., Liu L., Mo Z., et al. An inactivated enterovirus 71 vaccine in healthy children. New England Journal of Medicine. 2014;370(9):829&#x2013;837. doi: 10.1056/NEJMoa1303224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1303224</ArticleId><ArticleId IdType="pubmed">24571755</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W., Dai W., Zhang C., et al. A virus-like particle-based tetravalent vaccine for hand, foot, and mouth disease elicits broad and balanced protective immunity. Emerging Microbes &amp; Infections. 2018;7(1):1&#x2013;12. doi: 10.1038/s41426-018-0094-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41426-018-0094-1</ArticleId><ArticleId IdType="pmc">PMC5959873</ArticleId><ArticleId IdType="pubmed">29777102</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim H., in H. J., Lee J.-A., et al. The immunogenicity and protection effect of an inactivated coxsackievirus A6, A10, and A16 vaccine against hand, foot, and mouth disease. Vaccine. 2018;36(24):3445&#x2013;3452. doi: 10.1016/j.vaccine.2018.05.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2018.05.005</ArticleId><ArticleId IdType="pubmed">29739716</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyet L. A., Thanh T. T., Nhan N., et al. Neutralizing Antibodies against Enteroviruses in Patients with Hand, Foot and Mouth Disease. Emerging Infectious Diseases. 2020;26(2):298&#x2013;306. doi: 10.3201/eid2602.190721.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2602.190721</ArticleId><ArticleId IdType="pmc">PMC6986819</ArticleId><ArticleId IdType="pubmed">31961293</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi S., Metcalf C. J. E., Arima Y., et al. Epidemic dynamics, interactions and predictability of enteroviruses associated with hand, foot and mouth disease in Japan. Journal of the Royal Society Interface. 2018;15(146):p. 20180507. doi: 10.1098/rsif.2018.0507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsif.2018.0507</ArticleId><ArticleId IdType="pmc">PMC6170776</ArticleId><ArticleId IdType="pubmed">30209044</ArticleId></ArticleIdList></Reference><Reference><Citation>Pons-Salort M., Grassly N. C. Serotype-specific immunity explains the incidence of diseases caused by human enteroviruses. Science. 2018;361(6404):800&#x2013;803. doi: 10.1126/science.aat6777.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aat6777</ArticleId><ArticleId IdType="pmc">PMC6559928</ArticleId><ArticleId IdType="pubmed">30139872</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>